Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Wenyu Yu, Emma J. Chory, Amy K. Wernimont et al. · Nature Communications · 2012
Cited by 281 works. doi:10.1038/ncomms2304 Open-access PDF
Authors
- Wenyu Yu
- Emma J. Chory
- Amy K. Wernimont
- W. Tempel
- Alex P. Scopton
- Alexander Joel Federation
- Jason Marineau
- Jun Qi
- Dalia Baršytė-Lovejoy
- Richard C. Marcellus
- Roxana E. Iacob
- John R. Engen
- Carly Griffin
- Ahmed M. Aman
- Erno Wienholds
- Fengling Li
- Javier J. Pineda
- Guillermina Lucia Estiu
- Tatiana Shatseva
References
- Methylation of H3-Lysine 79 Is Mediated by a New Family of HMTases without a SET Domain
- MLL translocations, histone modifications and leukaemia stem-cell development
- Epigenetic protein families: a new frontier for drug discovery
- Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- Hydrogen exchange mass spectrometry for the analysis of protein dynamics
- H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- The art of the chemical probe
- DOT1L/KMT4 Recruitment and H3K79 Methylation Are Ubiquitously Coupled with Gene Transcription in Mammalian Cells